Φορτώνει......
Discovery, Optimization, and Characterization of Novel D(2) Dopamine Receptor Selective Antagonists
[Image: see text] The D2 dopamine receptor (D2 DAR) is one of the most validated drug targets for neuropsychiatric and endocrine disorders. However, clinically approved drugs targeting D2 DAR display poor selectivity between the D2 and other receptors, especially the D3 DAR. This lack of selectivity...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Med Chem |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
American Chemical
Society
2014
|
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4315423/ https://ncbi.nlm.nih.gov/pubmed/24666157 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm500126s |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|